Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

CCL2 antibody

CCL2 Reactivity: Human WB, IHC (p), FACS, Func, IHC (fro) Host: Mouse Monoclonal MNA-1 unconjugated
Catalog No. ABIN2191875
  • Target See all CCL2 Antibodies
    CCL2 (Chemokine (C-C Motif) Ligand 2 (CCL2))
    Reactivity
    • 96
    • 62
    • 58
    • 18
    • 18
    • 18
    • 16
    • 9
    • 3
    • 3
    • 2
    • 1
    • 1
    Human
    Host
    • 119
    • 53
    • 8
    • 7
    • 3
    • 2
    • 2
    Mouse
    Clonality
    • 135
    • 59
    Monoclonal
    Conjugate
    • 104
    • 33
    • 14
    • 7
    • 4
    • 4
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    This CCL2 antibody is un-conjugated
    Application
    • 138
    • 70
    • 57
    • 26
    • 26
    • 25
    • 24
    • 18
    • 15
    • 15
    • 13
    • 12
    • 12
    • 10
    • 10
    • 6
    • 2
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Flow Cytometry (FACS), Functional Studies (Func), Immunohistochemistry (Frozen Sections) (IHC (fro))
    Cross-Reactivity (Details)
    Cross reactivity: Human MCP-2 : No, Human MCP-3 : No, Porcine MCP-1 : Yes
    Sterility
    0.2 μm filtered
    Clone
    MNA-1
    Isotype
    IgG1
    Top Product
    Discover our top product CCL2 Primary Antibody
  • Application Notes
    For immunohistochemistry, flow cytometry and Western blotting, dilutions to be used depend on detection system applied. It is recommended that users test the reagent and determine their own optimal dilutions. The typical starting working dilution is 1:50. For functional studies dilutions have to be optimized in user's experimental setting.
    Restrictions
    For Research Use only
  • Buffer
    PBS, containing 0.1 % bovine serum albumin.
    Storage
    4 °C
    Storage Comment
    Product should be stored at 4 °C. Under recommended storage conditions, product is stable for at least one year. The exact expiry date is indicated on the label.
  • Wysocki, Zheng, Smith, Lamawansa, Iacopetta, Robertson, Papadimitriou, House, Norman: "Monocyte chemoattractant protein-1 gene expression in injured pig artery coincides with early appearance of infiltrating monocyte/macrophages." in: Journal of cellular biochemistry, Vol. 62, Issue 3, pp. 303-13, (1997) (PubMed).

    Peri, Milanese, Matteucci, Ruco, Zhou, Sozzani, Coletta, Mantovani: "A new monoclonal antibody (5D3-F7) which recognizes human monocyte-chemotactic protein-1 but not related chemokines. Development of a sandwich ELISA and in situ detection of producing cells." in: Journal of immunological methods, Vol. 174, Issue 1-2, pp. 249-57, (1994) (PubMed).

  • Target
    CCL2 (Chemokine (C-C Motif) Ligand 2 (CCL2))
    Alternative Name
    Monocyte Chemotactic Protein-1 (CCL2 Products)
    Synonyms
    GDCF-2 antibody, HC11 antibody, HSMCR30 antibody, MCAF antibody, MCP-1 antibody, MCP1 antibody, SCYA2 antibody, SMC-CF antibody, AI323594 antibody, JE antibody, Scya2 antibody, Sigje antibody, MCP-1A antibody, MCP1A antibody, C-C motif chemokine ligand 2 antibody, chemokine (C-C motif) ligand 2 antibody, C-C motif chemokine 2 antibody, CCL2 antibody, Ccl2 antibody, LOC101120093 antibody
    Background
    Monoclonal antibody MNA.1 (formerly known as 5D3-F7) recognizes human natural and recombinant monocyte chemotactic protein-1 (MCP-1). Monocyte chemotactic protein-1 (MCP-1) is a 11 kDa protein belonging to the CC subgroup of the chemokine superfamily, which stimulate the migration of monocytic cells. In contrast, the CXC chemokines predominantly activate polymorphonuclear leukocytes. The coordinated synthesis and release of MCP-1 plays a central role in both acute and chronic inflammatory processes by controlling the influx of phagocytic cells. Furthermore, their state of activation is in concert with primary inflammatory cytokines, such as IL-1, TNF-a, and IL-6. A selective accumulation of MCP-1 in the cerebrospinal fluid (CSF) of AIDS patients with cytomegalovirus encephalitis, but not with other opportunistic infections or primary lymphomas of the central nervous system , has been described. Furthermore, the chemotactic activity of MCP-1 on monocytic cells has been suggested to play a role in psoriasis, rheumatoid arthritis and atherosclerosis. No cross- reactivity of mAb MNA.1 with other cytokines has been detected. Aliases C-C motif chemokine 2, CCL2, small-inducible cytokine A2, MCAF, HC11 Immunogen Recombinant human MCP-1
    Pathways
    Cellular Response to Molecule of Bacterial Origin, Positive Regulation of Immune Effector Process, ER-Nucleus Signaling, Unfolded Protein Response, The Global Phosphorylation Landscape of SARS-CoV-2 Infection
You are here:
Support